Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIFT: Genetics Informatics Trial of Warfarin to Prevent DVT
NCT01006733Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2011
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin in venous thromboembolism (VTE), deep vein thrombosis (DVT), sponsored by Washington University School of Medicine. Started Mar 2011; status: completed.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT01006733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006733.